Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
adenocarcinoma, Aetna, agonist, Alameda, Alkem, alpha, antibody, antineoplastic, antitumor, Apotex, Arabia, argument, arisen, Ascent, ASD, autism, BC, BeiGene, biliary, Biophore, biparatopic, bispecific, bore, breast, BTC, chargeable, clawback, clearance, colorectal, Comment, counterclaim, dialogue, disciplined, divest, divestiture, divestment, driver, EPS, FDII, gamma, ganaxolone, gastroesophageal, gather, gave, GEA, globe, greatly, haptic, HHS, Hydroxybutyrate, IFN, INDUKINE, inflationary, interferon, intervene, InvaGen, invasion, inventorship, IRA, Irritability, lifelong, lifted, Limb, MAA, MAPK, military, Monocarboxylate, monopolization, MSN, NHS, oncogenic, palbociclib, Parkinson, platinum, poorly, potent, precondition, President, protein, Pvt, readout, rechallenge, Remix, RFC, rulemaking, Russia, Saudi, sharpen, Sherman, speaking, spectrum, subpoena, Sumitomo, Takeda, Taro, Tech, tetrahydrocannabinol, thousand, tislelizumab, town, tract, Ukrainian, unaltered, undermining, untreated, vast, WAC, Werewolf, zanidatamab, Zenara
Removed:
activation, Aerial, airway, ARRC, Asia, bearing, bin, box, combine, compromise, conjugate, constitute, convert, CPAP, deducting, derive, discrete, distracted, endothelial, extinguishment, feature, ImmunoGen, indicted, invent, Italian, killing, Labour, Laden, Licence, metabolite, Milosevic, mobile, neurotransmitter, Novation, OPi, opt, OSA, Osama, Overnight, paced, partner, persist, proof, regime, removing, safely, salt, SAS, separated, settling, Simplifying, SK, Slobodan, SOFR, space, Supplementary, sustainably, Swing, Tribunal, ultimate, unaudited, undergoing, unexpired, usage, Yugoslavia
Filing tables
Filing exhibits
- 10-K Annual report
- 4.6 Description of Share Capital
- 10.8 Pharmacy Master Services Agreement
- 10.26 Amended 2011 Equity Incentive Plan
- 10.30 Amended and Restated 2007 Employee Stock Purchase Plan
- 21.1 List of Subsidiaries
- 23.1 Consent of Independent Registered Public Accounting Firm
- 31.1 Certification of CEO Pursuant to Rules 13A-14(A) and 15D-14(A)
- 31.2 Certification of CFO Pursuant to Rules 13A-14(A) and 15D-14(A)
- 32.1 Certifications of CEO and CFO Pursuant to 18 U.s.c. Section 1350
- Download Excel data file
- View Excel data file
Related press release
Associated JAZZ transcripts
JAZZ similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the registration statements (No. 333-179075, No. 333-186886, No. 333-194131, No. 333-202269, No. 333-209767, No. 333-216338, No. 333-224757, No. 333‑229889, No. 333-236636, No. 333-249807, No. 333-253417, No. 333-255895 and No. 333-263195) on Form S-8 of our reports dated March 1, 2023, with respect to the consolidated financial statements and financial statement schedule at Item 15(a)2 of Jazz Pharmaceuticals plc and the effectiveness of internal control over financial reporting.
/s/ KPMG
Dublin, Ireland
March 1, 2023